William Blair Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.85 -0.36 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.21 | 52 Week High | $63.73 | |||
| Open | $18.25 | 52 Week Low | $8.00 | |||
| Day High | $18.53 | P/E | N/A | |||
| Day Low | $17.68 | EPS | $-5.69 | |||
| Volume | 3,015,057 | |||||
